PCSK9 Emerges as Early Marker of Autoimmune Liver Disease
A new study suggests that the cholesterol-regulating protein PCSK9 may serve as a sensitive early biomarker for autoimmune liver diseases, helping identify patients even when routine liver tests appear normal.








